Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-125369
Filing Date
2024-11-12
Accepted
2024-11-12 16:08:57
Documents
67
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q crgx-20240930.htm   iXBRL 10-Q 2640568
2 EX-10.1 crgx-ex10_1.htm EX-10.1 38578
3 EX-10.2 crgx-ex10_2.htm EX-10.2 58666
4 EX-31.1 crgx-ex31_1.htm EX-31.1 13620
5 EX-31.2 crgx-ex31_2.htm EX-31.2 13428
6 EX-32.1 crgx-ex32_1.htm EX-32.1 12537
7 GRAPHIC img28000435_0.jpg GRAPHIC 60247
  Complete submission text file 0000950170-24-125369.txt   9356576

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT crgx-20240930.xsd EX-101.SCH 1519526
70 EXTRACTED XBRL INSTANCE DOCUMENT crgx-20240930_htm.xml XML 1219076
Mailing Address 835 INDUSTRIAL ROAD, SUITE 400 SAN CARLOS CA 94070
Business Address 835 INDUSTRIAL ROAD, SUITE 400 SAN CARLOS CA 94070 650-499-8950
CARGO Therapeutics, Inc. (Filer) CIK: 0001966494 (see all company filings)

EIN.: 844080422 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41859 | Film No.: 241448119
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)